Image Source: Unsplash

For the trading week ended November 22, 2024 my proprietary Canadian Cannabis Company Index (MCCCI) was unchanged compared to the prior weekwhen it decreased by 5.9%. The index consists of 14 stocks, many of which are among the most widely held holdings of the 3 ETFs (MJ, CNBS, and THCX) that I consider to be a reliable barometer of the Canadian cannabis sector. MCCCI's differentiated business model is both weighted and market capitalization-based because I believe that this approach best represents the current landscape of the Canadian cannabis sector. Now let us at this  week’s good, bad, and ugly stocks, shall we?

The Good

There were no stocks that increased by more than 10%, which is my metric for inclusion in this category.

The Bad

There were no stocks that decreased by more than 10% (but less than 20%) which is my metric for inclusion in this category.

The Ugly

There were no stocks that decreased by 20% or more, which is my metric for inclusion in this category.

Valuation Metric Review

There was a de minimus decrease of 0.08% in the “Big 4” (3 of which increased) compared to the prior week when there was a 4.8% decrease. The stock-price based metric increased by 1.4% compared to the prior week when it decreased by 7.7%.

Recap

There was a 1.9% decrease in the relative strength index compared to the prior week when there was a 22.4% decrease. 4 of the 14 MCCCI stocks increased; led by Canopy Growth Corporation (CGC), which increased by 6.0%. DEFCON 1 alert remains in effect, given weak metrics. Let us see how this volatile sector has performed at the same time next week, shall we?

More By This Author:

The Canadian Cannabis Report - Monday, Nov 18
The Canadian Cannabis Report- Monday, Nov 11
The Canadian Cannabis Report - Monday, Nov. 4